-
A supply gap of more than 1 billion autodisable syringes could impact COVID-19 immunization efforts in 100 countries
prnasia
November 18, 2021
New PATH modeling estimates a global market supply gap of 1.2 billion autodisable (AD) syringe safe-injection devices for COVID-19 vaccine delivery.
-
GSK, PATH, Bharat Biotech sign product transfer agreement for malaria vaccine
expresspharma
January 28, 2021
Transfer builds on commitments to donate up to 10 million vaccine doses to the pilot implementation in regions of Ghana, Kenya, and Malawi and supply up to 15 million doses annually to 2028 if recommended for wider use.
-
$4.3m donated to PATH’s Visualise No Malaria scheme
pharmaceutical-technology
April 26, 2019
At a World Malaria Day event in Paris, four technology companies have announced they will contribute $4.3m in technical support to healthcare non-profit PATH’s Visualise No Malaria project.
-
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria
biospectrumasia
April 23, 2019
The goal of VivAccess is to support introduction and increased access to the suite of radical cure products to address these challenges
-
Gates Foundation commits $120M for nonprofit PATH's vaccine work
fiercepharma
September 07, 2017
RELATED: PATH, research institutes to test novel malaria vaccine in humans
-
New WHO designation for Oxygen
pharmaasia
June 14, 2017
Additional listing for oxygen on the Model List of Essential Medicines part of broader effort by PATH and other organizations to improve global health by making oxygen more accessible.
-
PATH, research institutes to test novel malaria vaccine in humans
fiercepharma
June 07, 2017
Scientists from three different countries are building on his approach in a novel malaria vaccine to be tested in humans.